patent/EP-1666598-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1666598-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85c017b34a1cfc399d0b8d9fa8eaef60
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24221
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-51
filingDate	2004-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f88660f9e5e2a3a83429bec5055ee1d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d465caa50f2006887f639b0415681dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_204812a506ea03bb2d05ca00c3863360 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bfd448da6a5a4a4cf63d5d2b420ea9c
publicationDate	2006-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EP-1666598-A1
titleOfInvention	Nucleic acid and gene originating in novel hcv strain and replicon-replicating cell using the gene
abstract	The present invention relates to a gene derived from a novel fulminant hepatitis C virus strain, an HCV replicon RNA with a high replication efficiency obtained using the gene, and an HCV replicon-replicating cell transfected with the replicon RNA. When the HCV replicon RNA and the HCV replicon-replicating cell of the present invention are used, HCV proteins can be continuously produced in a large amount.
priorityDate	2003-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003009775-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400163 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395503 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11057 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8378 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791

Total number of triples: 37.